CWP
JAZZ icon

CFM Wealth Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

CFM Wealth Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,624
Closed -$280K – 147
2024
Q2 		$280K Sell
2,624
-1,560
-37% -$172K 0.05% 126
2024
Q1 		$504K Sell
4,184
-294
-7% -$36K 0.1% 108
2023
Q4 		$551K Buy
+4,478
New +$559K 0.12% 104
2023
Q3 		– Sell
-4,585
Closed -$568K – 149
2023
Q2 		$568K Sell
4,585
-677
-13% -$91.1K 0.14% 102
2023
Q1 		$770K Buy
+5,262
New +$778K 0.21% 84
2022
Q4 		– Sell
-5,262
Closed -$701K – 158
2022
Q3 		$701K Hold
5,262
– – 0.22% 86
2022
Q2 		$821K Sell
5,262
-119
-2% -$18.3K 0.25% 83
2022
Q1 		$838K Sell
5,381
-96
-2% -$13.9K 0.2% 88
2021
Q4 		$718K Sell
5,477
-909
-14% -$119K 0.16% 94
2021
Q3 		$831K Sell
6,386
-75
-1% -$11.3K 0.21% 88
2021
Q2 		$1.15M Sell
6,461
-350
-5% -$60.6K 0.3% 68
2021
Q1 		$1.12M Sell
6,811
-2,670
-28% -$439K 0.34% 68
2020
Q4 		$1.56M Sell
9,481
-82
-0.9% -$12.2K 0.5% 49
2020
Q3 		$1.36M Sell
9,563
-1,955
-17% -$242K 0.5% 44
2020
Q2 		$1.27M Sell
11,518
-2,675
-19% -$296K 0.48% 48
2020
Q1 		$1.42M Buy
+14,193
New +$1.84M 0.66% 40

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CFM Wealth Partners's JAZZ Position: Q3 2024 in Review

CFM Wealth Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2024, closing a stake of 2,624 shares — an estimated $280K sold.

CFM Wealth Partners first reported a position in JAZZ in Q1 2020 and held it in 16 quarters. The position peaked at $1.56M in Q4 2020. 477 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • CFM Wealth Partners reported no remaining Jazz Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • CFM Wealth Partners sold 2,624 Jazz Pharmaceuticals shares in Q3 2024, an estimated $280K.
  • CFM Wealth Partners first reported a position in Jazz Pharmaceuticals in Q1 2020 and held it in 16 quarters.
  • CFM Wealth Partners's Jazz Pharmaceuticals position peaked at $1.56M in Q4 2020.
  • 477 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on CFM Wealth Partners's 13F filing for Q3 2024, filed 15 Oct 2024.